1631P Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) + bintrafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC)

Brachyury
DOI: 10.1016/j.annonc.2024.08.1712 Publication Date: 2024-09-17T20:46:44Z